220 related articles for article (PubMed ID: 32697042)
41. The altered renal and hepatic expression of solute carrier transporters (SLCs) in type 1 diabetic mice.
Xu C; Zhu L; Chan T; Lu X; Shen W; Gillies MC; Zhou F
PLoS One; 2015; 10(3):e0120760. PubMed ID: 25789863
[TBL] [Abstract][Full Text] [Related]
42. Solute Carrier Transporters as Potential Targets for the Treatment of Metabolic Disease.
Schumann T; König J; Henke C; Willmes DM; Bornstein SR; Jordan J; Fromm MF; Birkenfeld AL
Pharmacol Rev; 2020 Jan; 72(1):343-379. PubMed ID: 31882442
[TBL] [Abstract][Full Text] [Related]
43. An Overview of Cell-Based Assay Platforms for the Solute Carrier Family of Transporters.
Dvorak V; Wiedmer T; Ingles-Prieto A; Altermatt P; Batoulis H; Bärenz F; Bender E; Digles D; Dürrenberger F; Heitman LH; IJzerman AP; Kell DB; Kickinger S; Körzö D; Leippe P; Licher T; Manolova V; Rizzetto R; Sassone F; Scarabottolo L; Schlessinger A; Schneider V; Sijben HJ; Steck AL; Sundström H; Tremolada S; Wilhelm M; Wright Muelas M; Zindel D; Steppan CM; Superti-Furga G
Front Pharmacol; 2021; 12():722889. PubMed ID: 34447313
[TBL] [Abstract][Full Text] [Related]
44. Long evolutionary conservation and considerable tissue specificity of several atypical solute carrier transporters.
Sreedharan S; Stephansson O; Schiöth HB; Fredriksson R
Gene; 2011 Jun; 478(1-2):11-8. PubMed ID: 21044875
[TBL] [Abstract][Full Text] [Related]
45. Heterologous (Over) Expression of Human SoLute Carrier (SLC) in Yeast: A Well-Recognized Tool for Human Transporter Function/Structure Studies.
Pochini L; Galluccio M
Life (Basel); 2022 Aug; 12(8):. PubMed ID: 36013385
[TBL] [Abstract][Full Text] [Related]
46. Advances and Challenges in Rational Drug Design for SLCs.
Garibsingh RA; Schlessinger A
Trends Pharmacol Sci; 2019 Oct; 40(10):790-800. PubMed ID: 31519459
[TBL] [Abstract][Full Text] [Related]
47. The Novel Membrane-Bound Proteins MFSD1 and MFSD3 are Putative SLC Transporters Affected by Altered Nutrient Intake.
Perland E; Hellsten SV; Lekholm E; Eriksson MM; Arapi V; Fredriksson R
J Mol Neurosci; 2017 Feb; 61(2):199-214. PubMed ID: 27981419
[TBL] [Abstract][Full Text] [Related]
48. Increased/Targeted Brain (Pro)Drug Delivery via Utilization of Solute Carriers (SLCs).
Huttunen J; Adla SK; Markowicz-Piasecka M; Huttunen KM
Pharmaceutics; 2022 Jun; 14(6):. PubMed ID: 35745806
[TBL] [Abstract][Full Text] [Related]
49. The Roles of Solute Carriers in Auditory Function.
Qian F; Jiang X; Chai R; Liu D
Front Genet; 2022; 13():823049. PubMed ID: 35154281
[TBL] [Abstract][Full Text] [Related]
50. Welcome to the Family: Identification of the NAD
Ziegler M; Monné M; Nikiforov A; Agrimi G; Heiland I; Palmieri F
Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34198503
[TBL] [Abstract][Full Text] [Related]
51. Detection of Chemical Engagement of Solute Carrier Proteins by a Cellular Thermal Shift Assay.
Hashimoto M; Girardi E; Eichner R; Superti-Furga G
ACS Chem Biol; 2018 Jun; 13(6):1480-1486. PubMed ID: 29851333
[TBL] [Abstract][Full Text] [Related]
52. Drug target ontology to classify and integrate drug discovery data.
Lin Y; Mehta S; Küçük-McGinty H; Turner JP; Vidovic D; Forlin M; Koleti A; Nguyen DT; Jensen LJ; Guha R; Mathias SL; Ursu O; Stathias V; Duan J; Nabizadeh N; Chung C; Mader C; Visser U; Yang JJ; Bologa CG; Oprea TI; Schürer SC
J Biomed Semantics; 2017 Nov; 8(1):50. PubMed ID: 29122012
[TBL] [Abstract][Full Text] [Related]
53. mOWL: Python library for machine learning with biomedical ontologies.
Zhapa-Camacho F; Kulmanov M; Hoehndorf R
Bioinformatics; 2023 Jan; 39(1):. PubMed ID: 36534832
[TBL] [Abstract][Full Text] [Related]
54. Functional classification of membrane transporters and channels based on filtered TM/non-TM amino acid composition.
Schaadt NS; Helms V
Biopolymers; 2012 Jul; 97(7):558-67. PubMed ID: 22492257
[TBL] [Abstract][Full Text] [Related]
55. Deleterious nonsynonymous single nucleotide polymorphisms in human solute carriers: the first comparison of three prediction methods.
Hao DC; Xiao B; Xiang Y; Dong XW; Xiao PG
Eur J Drug Metab Pharmacokinet; 2013 Mar; 38(1):53-62. PubMed ID: 22555822
[TBL] [Abstract][Full Text] [Related]
56. Solute carrier proteins and c-Myc: a strong connection in cancer progression.
Panda S; Banerjee N; Chatterjee S
Drug Discov Today; 2020 May; 25(5):891-900. PubMed ID: 32105718
[TBL] [Abstract][Full Text] [Related]
57. Solute transporters and malignancy: establishing the role of uptake transporters in breast cancer and breast cancer metastasis.
Sutherland R; Meeson A; Lowes S
Cancer Metastasis Rev; 2020 Sep; 39(3):919-932. PubMed ID: 32388639
[TBL] [Abstract][Full Text] [Related]
58. Emerging roles of the solute carrier family in pancreatic cancer.
Wu Z; Xu J; Liang C; Meng Q; Hua J; Wang W; Zhang B; Liu J; Yu X; Shi S
Clin Transl Med; 2021 Mar; 11(3):e356. PubMed ID: 33783998
[TBL] [Abstract][Full Text] [Related]
59.
César-Razquin A; Girardi E; Yang M; Brehme M; Saez-Rodriguez J; Superti-Furga G
Front Pharmacol; 2018; 9():1011. PubMed ID: 30245630
[TBL] [Abstract][Full Text] [Related]
60. The inhibitory effects of the bioactive components isolated from Scutellaria baicalensis on the cellular uptake mediated by the essential solute carrier transporters.
Xu F; Li Z; Zheng J; Gee Cheung FS; Chan T; Zhu L; Zhuge H; Zhou F
J Pharm Sci; 2013 Nov; 102(11):4205-11. PubMed ID: 24018852
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
